Bacterial floras and biofilms of malignant wounds associated with breast cancers

Journal of Clinical Microbiology

Volumn 51, Issue 10, 2013, Pages 3368-3373

  Fromantin, Isabelle ^a,b   Seyer, Damien ^b   Watson, Sarah ^a   Rollot, Florence ^a   Elard, Jacqueline ^a   Escande, Marie Christine ^a   De Rycke, Yann ^a   Kriegel, Irène ^c   Garde, Véronique Larreta ^b  

^a Department of Supportive Care ^*  (United States)

^b UNIVERSITÉ DE CERGY PONTOISE   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AEROBIC BACTERIUM; AGED; ANAEROBIC BACTERIUM; APLASIA; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BIOFILM; BREAST CANCER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORYNEBACTERIUM STRIATUM; DISEASE ASSOCIATION; ENTEROCOCCUS FAECALIS; EPIFLUORESCENCE MICROSCOPY; ESCHERICHIA COLI; EXPERIMENTAL STUDY; FEMALE; HUMAN; INFECTION RISK; KLEBSIELLA OXYTOCA; MALE; MALIGNANT WOUND; NONHUMAN; ODOR; PAIN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; SYMPTOM; WOUND; WOUND FLUID; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; BIOTA; BREAST NEOPLASMS; COINFECTION; FEMALE; HUMANS; MIDDLE AGED; WOUND INFECTION;

EID: 84884808139     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01277-13     Document Type: Article

References (33)

1. Grocott P. 1999. The management of fungating wounds. J. Wound Care 8:232-234.
2. McMurray V. 2003. Managing patients with fungating malignant wounds. Nurs. Times 99:55-57.
3. Langemo DK, Anderson J, Hanson D, Hunter S, Thompson P. 2007. Managing fungating wounds. Adv. Skin Wound Care 20:312-314.
4. Meaume S, Kerihuel JC, Fromantin I, Teot L. 2012. Workload and prevalence of open wounds in the community: French Vulnus initiative. J. Wound Care 21:62-73.
5. Probst S, Arber A, Faithfull S. 2009. Malignant fungating wounds: a survey of nurses' clinical practice in Switzerland. Eur. J. Oncol. Nurs. 13:295-298.
6. Lookingbill DP, Spangler N, Helm KF. 1993. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J. Am. Acad. Dermatol. 29(2 Pt 1):228-236. (Pubitemid 23221903)
7. Clark J. 2002. Metronidazole gel in managing malodorous fungating wounds. Br. J. Nurs. 11(6 Suppl):S54-S60.
8. Stotter A, Kroll S, McNeese M, Holmes F, Oswald MJ, Romsdahl M. 1991. Salvage treatment for loco-regional recurrence following breast conservation therapy for early breast cancer. Eur. J. Surg. Oncol. 17:231-236.
9. Lund-Nielsen B, Müller K, Adamsen L. 2005. Malignant wounds in women with breast cancer: feminine and sexual perspectives. J. Clin. Nurs. 14:56-64. (Pubitemid 40221630)
10. Dowsett C. 2002. Malignant fungating wounds: assessment and management. Br. J. Community Nurs. 7:394-400.
11. Lazelle-Ali C. 2007. Psychological and physical care of malodorous fungating wounds. Br. J. Nurs. 16:S16-S24.
12. Bowler PG, Davies BJ. 1999. The microbiology of infected and noninfected leg ulcers. Int. J. Dermatol. 38:573-578. (Pubitemid 29404785)
13. Black CE, Costerton JW. 2010. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg. Clin. North Am. 90:1147-1160.
14. Philips P, Sampson E, Yang Q, Antonelli P, Progulske-Fox A, Schultz G. 2008. Bacterial biofilms in wound. Wound Heal. S. Afr. 1:10-12.
15. Kirketerp-Moller K, Jensen P, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Hoiby N, Givskov M, Bjarnsholt T. 2008. Distribution, organisation, and ecology of bacteria in chronic wounds. J. Clin. Microbiol. 46:2717-2722.
16. Ammons MC. 2010. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat. Antiinfect. Drug Discov. 5:10-17.
17. Wilson M. 2001. Bacterial biofilms and human disease. Sci. Prog. 84(Pt 3):235-254.
18. James GA, Swogger E, Wolcott R, Pulcini ED, Secor P, Sestrich J, Costerton JW, Stewart PS. 2008. Biofilms in chronic wounds. Wounds Repair Regen. 16:37-44.
19. Rhoads DD, Cox SB, Rees EJ, Sun Y, Wolcott RD. 2012. Clinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing. BMC Infect. Dis. 12:321.
20. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, Bowers J, Rattray R, Ravel J, Kingsley C, Keim PS, Lazarus GS, Zenilman JM. 2009. Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 4:e6462. doi:10.1371/journal.pone.0006462.
21. Bowler PG, Duerden B, Armstrong DG. 2001. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev. 14: 244-269. (Pubitemid 32294670)
22. Hansson C, Andersson E, Swanbeck G. 1988. Leg ulcer epidemiology in Gothenburg. Acta Chir. Scand. Suppl. 544:12-16.
23. Lund-Nielsen B, Adamsen L, Gottrup F, Rorth M, Tolver A, Kolmos JK. 2011. Qualitative bacteriology in malignant wounds-a prospective, randomized, clinical study to compare the effect of honey and silver dressing. Ostomy Wound Manage. 57:28-36.
24. Rotimi VO, Durosinmi Etti FA. 1984. The bacteriology of infected malignant ulcers. J. Clin. Pathol. 37:592-595. (Pubitemid 14135882)
25. Ingham HR, Sisson PR, Tharagonnet D, Selkon JB, Codd AA. 1977. Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet ii:1252-1254. (Pubitemid 8285408)
26. Ashford RFU, Plant GT, Maher J, Pickering D, Coe MA, Drury A, Goold MA, Teare EL. 1980. Metrodinazole in smelly tumours. Lancet i:874-875.
27. Seaman S. 2006. Management of malignant fungating wounds in advanced cancer. Semin. Oncol. Nurs. 22:185-193. (Pubitemid 44163103)
28. Andriessen AE, Eberlein T. 2008. Assessment of a wound cleansing solution in the treatment of problem wounds. Wounds 20:171-175.
29. Kaerhn K, Eberlein T. 2009. In-vitro test for comparing the efficacy of wound rinsing solutions. Br. J. Nurs. 8:S4, S6-S8, S10.
30. Wolcott RD, Rumbaugh KP, James G, Schultz G, Yang Q, Watters C, Stewart PS, Dowd SE. 2010. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J. Wound Care 19:320-328.
31. Cowan T. 2012. Visible biofilms-a controversial issue! J. Wound Care 21:106.
32. Hurlow J. 2012. Response to White and Cutting critique. J. Wound Care 21:198.
33. White RJ, Cutting KF. 2012. Wound biofilms-are they visible? J. Wound Care 21:140-141.